BRIEF — Telix Pharmaceuticals Says To Acquire ITM Isotope Technologies Munich SE for $1.65 billion

Sept 21 (Reuters) — Telix Pharmaceuticals Limited: After Adjustments, Itm Shareholders Expected To Be Paid Us$1.25 Billion In Telix Shares At Us$11.84per Share Telix And Itm Join Forces To Create Radiopharma Powerhouse Signed A Strategic Agreement To Lead A Merger With Itm Isotope Technologies Munich Se Upfront Consideration Of Us$1.65 Billion Additional Contingent Consideration Of Up To Us$700 Million Upon Achievement Of Future Regulatory Approvals, Others Combined Organization Is Expected To Generate Unaudited Pro Forma 2026 Revenue And Income Exceeding Us$1.3 Billion Signed A Strategic Agreement To Lead A Merger With Itm Isotope Technologies Munich Se Further company coverage: TLX.AX (Reuters.Briefs@thomsonreuters.com;)